PE61799A1 - Hidrocloruro de n-[3-[[2-(3,4-dimetoxifenil)etil]amino]propil]-4-nitrobenzamida hidratado - Google Patents

Hidrocloruro de n-[3-[[2-(3,4-dimetoxifenil)etil]amino]propil]-4-nitrobenzamida hidratado

Info

Publication number
PE61799A1
PE61799A1 PE1998000218A PE00021898A PE61799A1 PE 61799 A1 PE61799 A1 PE 61799A1 PE 1998000218 A PE1998000218 A PE 1998000218A PE 00021898 A PE00021898 A PE 00021898A PE 61799 A1 PE61799 A1 PE 61799A1
Authority
PE
Peru
Prior art keywords
hydrochloride
water
dimetoxifenil
propil
nitrobenzamide
Prior art date
Application number
PE1998000218A
Other languages
English (en)
Inventor
Graham Ralph Slater
Paul Jeffrey Westlake
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of PE61799A1 publication Critical patent/PE61799A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/78—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Abstract

CARACTERIZADO POR SU i)CONTENIDO DE AGUA EN LA PROPORCION DE 1,7 A 2,4 EQUIVALENTES MOLARES; ii)PUNTO DE FUSION SUPERIOR A 145�C; iii)ESPECTRO INFRAROJO; iv)ESPECTRO DE RESONANCIA MAGNETICA NUCLEAR EN ESTADO SOLIDO; v)PATRON DE DIFRACCION EN POLVO DE RAYOS X (XRPD). TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION DEL HIDROCLORURO HIDRATADO CARACTERIZADO PORQUE EL HIDROCLORURO SE HIDRATA CON UNA CANTIDAD REQUERIDA DE AGUA, UN METODO DE HIDRATACION ES LA CRISTALIZACIOON O RECRISTALIZACION EN AGUA O EN UN DISOLVENTE ACUOSO. EL HIDROCLORURO PUEDE SER UTIL EN EL TRATAMIENTO Y PROFILAXIS DE LA ARRITMIA Y LOS TRASTORNOS ISQUEMICOS DEL RITMO
PE1998000218A 1997-03-27 1998-03-25 Hidrocloruro de n-[3-[[2-(3,4-dimetoxifenil)etil]amino]propil]-4-nitrobenzamida hidratado PE61799A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9706376.2A GB9706376D0 (en) 1997-03-27 1997-03-27 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
PE61799A1 true PE61799A1 (es) 1999-09-10

Family

ID=10809958

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000218A PE61799A1 (es) 1997-03-27 1998-03-25 Hidrocloruro de n-[3-[[2-(3,4-dimetoxifenil)etil]amino]propil]-4-nitrobenzamida hidratado

Country Status (37)

Country Link
US (1) US20040092771A1 (es)
EP (1) EP0971882B1 (es)
JP (1) JP2001518088A (es)
KR (1) KR20010005566A (es)
CN (1) CN1257478A (es)
AP (1) AP1205A (es)
AT (1) ATE228997T1 (es)
AU (1) AU741476B2 (es)
BG (1) BG103829A (es)
BR (1) BR9809054A (es)
CA (1) CA2285197A1 (es)
DE (1) DE69809891T2 (es)
DK (1) DK0971882T3 (es)
DZ (1) DZ2452A1 (es)
EA (1) EA002439B1 (es)
EG (1) EG21226A (es)
ES (1) ES2189163T3 (es)
GB (1) GB9706376D0 (es)
HK (1) HK1025089A1 (es)
HU (1) HUP0001683A3 (es)
ID (1) ID22787A (es)
IL (1) IL132042A0 (es)
IN (1) IN188180B (es)
MA (1) MA26477A1 (es)
NO (1) NO994682D0 (es)
NZ (1) NZ337794A (es)
OA (1) OA11200A (es)
PE (1) PE61799A1 (es)
PL (1) PL335879A1 (es)
PT (1) PT971882E (es)
SK (1) SK283056B6 (es)
TR (1) TR199902356T2 (es)
TW (1) TW518318B (es)
UA (1) UA57066C2 (es)
UY (1) UY24937A1 (es)
WO (1) WO1998043947A1 (es)
ZA (1) ZA982558B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9923933D0 (en) * 1999-10-08 1999-12-08 Smithkline Beecham Lab Novel pharmaceutical
GB9923934D0 (en) * 1999-10-08 1999-12-08 Smithkline Beecham Plc Novel pharmaceutical
US8483008B2 (en) * 2008-11-08 2013-07-09 Westerngeco L.L.C. Coil shooting mode

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2726267B1 (fr) * 1994-10-26 1998-01-02 Smithkline Beecham Lab Nouveaux agents anti-arythmiques, compositions pharmaceutiques les contenant, et procede pour les preparer

Also Published As

Publication number Publication date
SK130299A3 (en) 2000-05-16
BG103829A (bg) 2000-04-28
UA57066C2 (uk) 2003-06-16
DE69809891D1 (de) 2003-01-16
OA11200A (en) 2003-05-21
EA002439B1 (ru) 2002-04-25
HK1025089A1 (en) 2000-11-03
NO994682L (no) 1999-09-24
HUP0001683A3 (en) 2002-11-28
DE69809891T2 (de) 2003-07-24
IL132042A0 (en) 2001-03-19
BR9809054A (pt) 2000-08-01
AP1205A (en) 2003-09-17
CA2285197A1 (en) 1998-10-08
TR199902356T2 (xx) 2000-01-21
MA26477A1 (fr) 2004-12-20
AP9901651A0 (en) 1999-09-30
AU7334198A (en) 1998-10-22
GB9706376D0 (en) 1997-05-14
HUP0001683A2 (hu) 2000-09-28
JP2001518088A (ja) 2001-10-09
EG21226A (en) 2001-03-31
ES2189163T3 (es) 2003-07-01
US20040092771A1 (en) 2004-05-13
AU741476B2 (en) 2001-11-29
SK283056B6 (sk) 2003-02-04
KR20010005566A (ko) 2001-01-15
NZ337794A (en) 2001-06-29
EP0971882B1 (en) 2002-12-04
DK0971882T3 (da) 2003-03-31
UY24937A1 (es) 2000-12-29
TW518318B (en) 2003-01-21
PL335879A1 (en) 2000-05-22
NO994682D0 (no) 1999-09-24
WO1998043947A1 (en) 1998-10-08
EA199900879A1 (ru) 2000-04-24
IN188180B (es) 2002-08-31
ZA982558B (en) 1999-09-27
EP0971882A1 (en) 2000-01-19
CN1257478A (zh) 2000-06-21
ATE228997T1 (de) 2002-12-15
ID22787A (id) 1999-12-09
DZ2452A1 (fr) 2003-01-18
PT971882E (pt) 2003-04-30

Similar Documents

Publication Publication Date Title
ATE129409T1 (de) Neue verwendung von peptidderivat.
CY2005A (en) 3-(2-(dimethylamino)ethyl)-N-methyl-1H-indole-5- methanesulphonamide sulphate (2:1)
LU91372I2 (fr) Retapamulin optionnellement sous forme d'un sel pharmaceutiquement acceptable (altargo)
NO20005161L (no) N,N-disubstituerte amider som inhiberer bindingen av integriner til deres reseptorer
RU93043528A (ru) Моногидрат 5-(2-(4-(1,2-бензотиазол-3-ил)-1-пиперазинил)этил)-6-хлор-1,3-дигидро-2н-индол-2-он хлоргидрата, способ его получения, фармацевтическая композиция, способ лечения
LU91306I2 (fr) Mitratapide, optionnellement sous forme d'un sel d'addition acide pharmaceutiquement acceptable (YARVITAN)
LU91131I2 (fr) Duloxétine et ses sels d'addition acides pharmaceutiquement acceptables, et en particulier, chlorhydrate de duloxétine.
PE58399A1 (es) Atropisomeros de 3-aril-4(3h)-quinazolinonas
MX9201963A (es) Benz iso tiazol y benz isoxazol -3- carboxamidas, un procedimiento para su preparacion y su uso como medicamentos.
HU9402827D0 (en) 4-[4'-piperidinyl or 3'pirrolidinyl] substituted imidazoles as h3-receptor antagonists and therapeutic uses thereof
PE61799A1 (es) Hidrocloruro de n-[3-[[2-(3,4-dimetoxifenil)etil]amino]propil]-4-nitrobenzamida hidratado
SE8500074D0 (sv) Vetelagringsmaterial
AR017213A1 (es) Un proceso para preparar un hidrato de la sal del acido maleico de la 5-[4-[2-(n-metil-n-(2-piridil)amino)-etoxi]bencil]tiazolidin-2,4-diona
FI94354C (fi) Menetelmä farmaseuttisesti aktiivisten peptidien valmistamiseksi
TWI255813B (en) Compounds for use as alphavbeta3 receptor antagonists
IN164207B (es)
DE689838T1 (de) Verwendung von Diademosim 5',5'''-p1,p4-Tetraphosphat zur Behandlung von ischämischen Myokard-Erkrankungen
GB2135997B (en) N-(m-trifluoromethylphenyl)-n'-propargylpiperazine
DE2960627D1 (en) 2-(n-(2'chloro-4'-methyl-thienyl-3')-n-(cyclopropylmethyl)-amino) imidazoline (2), its acid addition salts, pharmaceutical preparations containing them and process for their preparation
TR22096A (tr) 2-(3-piridil)-2-fenilaminoasetik asid'in yeni tuerevleri,bunlarin hazirlanmasi ve ziraat alaninda,antifungal olarak kullanilmasi
ZA993528B (en) A compound for use in treating glaucoma and ischemic retinopathy.
DE3064069D1 (en) (-)-alpha-(2-(bis(1-methylethyl)amino)ethyl)-alpha-phenyl-2-pyridineacetamide and pharmacologically acceptable salts thereof, process for the production thereof and compositions containing the same
HU9802875D0 (en) Process for producing 2-(methylthio)-5-(trifluoromethyl)-1,3,4-thiadiazole using methyldithio carbazinate and trifluoroacetic acid
PT82535A (en) Pharmacologically active propionylanilides
ITRM910590A1 (it) Procedimento ellettrochimico per la preparazione dell'acido 4, 4'- dinitrostilben- 2, 2, ' -disolfonico e dei relativi sali

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed